Initiator Pharma A/S (INIT) Stock Statistics & Valuation Metrics

Initiator Pharma A/S has a market cap or net worth of kr193.72M. The enterprise value is kr121.90M.

Initiator Pharma A/S has 68,452,890 shares outstanding. The number of shares has decreased by -2.65% in one year.

Initiator Pharma A/S’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -47.05%.

The current PE Ratio of Initiator Pharma A/S is ―. Initiator Pharma A/S’s PEG ratio is 0.00.

In the last 12 months, Initiator Pharma A/S had revenue of 0.00 and earned -14.01M in profits. Earnings per share was -0.23.

In the last 12 months, operating cash flow was -18.46M and capital expenditures 2.20M, giving a free cash flow of -18.69M billion.

Initiator Pharma A/S pays an annual dividend of ―, resulting in a dividend yield of ―

Initiator Pharma A/S upcoming earnings date is Aug 21, 2026, TBA (Confirmed).

Initiator Pharma A/S as a current ratio of 25.77, with Debt / Equity ratio of 41.80%

In the past 12 months, Initiator Pharma A/S has paid -3.08M in taxes.

Initiator Pharma A/S EV to EBITDA ratio is -5.67, with an EV/FCF ratio of -5.82.

Initiator Pharma A/S has kr19.90M in cash and marketable securities with kr7.56M in debt, giving a net cash position of kr12.34M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Initiator Pharma A/S is ―, which is 11.43% higher than the current price. The consensus rating is ―